DAVITA INC. Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount
DAVITA INC. (DVA) reported Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount of $282.83 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate · last filed 2026-02-11
- DAVITA INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2025 was $282.83M, a 12.00% decline from fiscal 2024.
- DAVITA INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2024 was $321.38M, a 30.01% increase from fiscal 2023.
- DAVITA INC. effective income tax rate reconciliation at federal statutory income tax rate, amount for fiscal 2023 was $247.19M.
| Period end | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount 12 month |
|---|---|
| 2025-12-31 | $282.83M 10-K · filed 2026-02-11 |
| 2024-12-31 | $321.38M 10-K · filed 2026-02-11 |
| 2023-12-31 | $247.19M 10-K · filed 2026-02-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| Progyny, Inc. (PGNY) | United States | $1.994B | 28.37 |
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |